Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosenquist

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Leukemia|May 14, 2010
Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolutionE Kostareli, L-A Sutton, A Hadzidimitriou, et al.
Leukemia|November 10, 2012
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemiaL Mansouri, N Cahill, R Gunnarsson, et al.
Leukemia|November 13, 2013
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohortD Cortese, L-A Sutton, N Cahill, et al.
Leukemia|April 2, 2011
Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic casesA W Langerak, F Davi, P Ghia, et al.
American Journal of Ophthalmology|June 1, 1984
A one-year multicenter clinical trial of pilocarpine gelD H Johnson, D L Epstein, R C Allen, et al.
Leukemia|March 11, 2005
Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemiaG Tobin, A Skogsberg, U Thunberg, et al.
Cancer Letters|March 21, 2008
Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarraysP Ellmark, C M Högerkorp, S Ek, et al.
European Journal of Haematology|September 15, 1999
Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemiaR Rosenquist, U Thunberg, A H Li, et al.
Leukemia|July 2, 2011
Impact of TP53 mutation and 17p deletion in mantle cell lymphomaA M Halldórsdóttir, A Lundin, F Murray, et al.
Leukemia|November 30, 2007
The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemiaM A Kaderi, M Norberg, F Murray, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Leukemia|May 14, 2010
Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolutionE Kostareli, L-A Sutton, A Hadzidimitriou, et al.
Leukemia|November 10, 2012
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemiaL Mansouri, N Cahill, R Gunnarsson, et al.
Leukemia|November 13, 2013
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohortD Cortese, L-A Sutton, N Cahill, et al.
Leukemia|April 2, 2011
Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic casesA W Langerak, F Davi, P Ghia, et al.
American Journal of Ophthalmology|June 1, 1984
A one-year multicenter clinical trial of pilocarpine gelD H Johnson, D L Epstein, R C Allen, et al.
Leukemia|March 11, 2005
Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemiaG Tobin, A Skogsberg, U Thunberg, et al.
Cancer Letters|March 21, 2008
Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarraysP Ellmark, C M Högerkorp, S Ek, et al.
European Journal of Haematology|September 15, 1999
Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemiaR Rosenquist, U Thunberg, A H Li, et al.
Leukemia|July 2, 2011
Impact of TP53 mutation and 17p deletion in mantle cell lymphomaA M Halldórsdóttir, A Lundin, F Murray, et al.
Leukemia|November 30, 2007
The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemiaM A Kaderi, M Norberg, F Murray, et al.
Pageof 6